HomeIPSC • NASDAQ
add
Century Therapeutics Inc
Previous close
$0.57
Day range
$0.55 - $0.59
Year range
$0.34 - $3.29
Market cap
48.59M USD
Avg Volume
864.08K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 109.16M | 12,667.72% |
Operating expense | 8.41M | -3.83% |
Net income | 76.56M | 372.82% |
Net profit margin | 70.13 | 102.14% |
Earnings per share | 0.89 | 297.78% |
EBITDA | 77.40M | 375.60% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 165.12M | -14.01% |
Total assets | 315.61M | -9.44% |
Total liabilities | 75.17M | -55.94% |
Total equity | 240.44M | — |
Shares outstanding | 86.16M | — |
Price to book | 0.20 | — |
Return on assets | 55.45% | — |
Return on capital | 72.96% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 76.56M | 372.82% |
Cash from operations | -34.62M | -14.46% |
Cash from investing | 27.93M | 142.01% |
Cash from financing | 120.00K | -99.34% |
Net change in cash | -6.57M | -1,183.79% |
Free cash flow | -63.51M | -222.42% |
About
Founded
2018
Headquarters
Website
Employees
140
